Down's syndrome

Los Angeles, CA, November 19 -- In a remarkable medical breakthrough, a team of researchers from the Stanford University, Calif., claim to have developed a drug which increases the levels of norepinephrine, a message-carrying chemical in the brain, thus easing the learning difficulties caused by Down’s syndrome, a chromosomal disorder which affects 5,000 newborns in the United States each year.